サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：合成低分子APIの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
市場調査レポート
商品コード
1342963

合成低分子APIの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測

Global Synthetic Small Molecule API Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 127 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
合成低分子APIの世界市場調査レポート：産業分析、規模、シェア、成長、動向、2023～2030年の予測
出版日: 2023年08月01日
発行: Value Market Research
ページ情報: 英文 127 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

合成低分子API市場の世界需要は、2022年の1,358億8,000万米ドルから2030年には2,729億9,000万米ドル近くの市場規模に達すると推定され、調査期間2023～2030年のCAGRは8.06%です。

合成低分子APIは低分子量の医薬品有効成分です。合成低分子APIは、生物学的手順や医薬品開発に使用される有機成分です。さらに、どんな完成医薬品もAPIを単独または組み合わせて利用することができます。医薬品分野では不可欠な主要成分です。この分子は病気の診断、予防、治療に非常に有効であることが証明されています。合成低分子APIの分子量は900ダルトンです。

市場力学：

低分子API市場は、製薬業界の技術進歩による合成低分子APIの生産量増加と、ジェネリック医薬品に対するニーズの高まりの両方から影響を受けています。合成低分子原薬の需要は、いくつかの治療分野における慢性疾患の効果的な治療法の必要性によって牽引されています。高齢化人口の増加、病気や治療に対する意識の高まり、研究開発活動の急増、ヘルスケアインフラの改善、医療費の増加は、合成低分子原薬の市場成長に寄与しているいくつかの要因です。医薬品・薬剤の低コスト製造のためのAPIのような原材料の需要によって、成長はさらに加速しています。アウトソーシング動向の増加と医薬品の小規模生産の急増は、合成低分子APIの市場成長をさらに増大させると思われます。

この調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、合成低分子APIの世界市場における各セグメントを包括的に評価することもできます。合成低分子API産業の成長と動向は、この調査に全体的なアプローチを提供します。

地域分析：

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける合成低分子API市場の現在と将来の需要を強調する地域展望をカバーします。さらに、本レポートでは、すべての主要地域における個々の用途セグメントの需要、推定・予測に焦点を当てています。

ご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 合成低分子API-業界分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 COVID-19発生の影響分析

第6章 合成低分子APIの世界市場分析：メーカー別

  • メーカー別概要
  • 実績データと予測データ
  • メーカー別分析
  • 自社
  • 外部委託

第7章 合成低分子APIの世界市場分析：用途別

  • 概要：用途別
  • 実績データと予測データ
  • 分析：用途別
  • 循環器
  • 腫瘍学
  • 中枢神経系
  • 整形外科
  • 内分泌学
  • 呼吸器内科
  • 消化器内科
  • 腎臓内科
  • 眼科
  • その他

第8章 合成低分子APIの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • その他アジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ

第9章 合成低分子API企業の競合情勢

  • 合成低分子API市場競争
  • 提携・共同研究・契約
  • 合併・買収
  • 新製品上市
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Bristol-Myers Squibb Company
  • Cipla Inc.
  • Boehringer Ingelheim International GmbH
  • Merck & Co. Inc.
  • AbbVie Inc.
  • Aurobindo Pharma
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Albemarle Corporation
  • Viatris Inc.
  • Dr. Reddy's Laboratories Ltd.
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Manufacturer (USD MN)
  • In-house Market Sales by Geography (USD MN)
  • Outsourced Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Cardiology Market Sales by Geography (USD MN)
  • Oncology Market Sales by Geography (USD MN)
  • CNS And Neurology Market Sales by Geography (USD MN)
  • Orthopedic Market Sales by Geography (USD MN)
  • Endocrinology Market Sales by Geography (USD MN)
  • Pulmonology Market Sales by Geography (USD MN)
  • Gastroenterology Market Sales by Geography (USD MN)
  • Nephrology Market Sales by Geography (USD MN)
  • Ophthalmology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Synthetic Small Molecule Api Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Synthetic Small Molecule Api Report
  • Market Research Process
  • Market Research Methodology
  • Global Synthetic Small Molecule Api Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Manufacturer
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Manufacturer (USD MN)
  • In-house Market Sales by Geography (USD MN)
  • Outsourced Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Cardiology Market Sales by Geography (USD MN)
  • Oncology Market Sales by Geography (USD MN)
  • CNS And Neurology Market Sales by Geography (USD MN)
  • Orthopedic Market Sales by Geography (USD MN)
  • Endocrinology Market Sales by Geography (USD MN)
  • Pulmonology Market Sales by Geography (USD MN)
  • Gastroenterology Market Sales by Geography (USD MN)
  • Nephrology Market Sales by Geography (USD MN)
  • Ophthalmology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR11219209

The global demand for Synthetic Small Molecule API Market is presumed to reach the market size of nearly USD 272.99 BN by 2030 from USD 135.88 BN in 2022 with a CAGR of 8.06% under the study period 2023 - 2030.

Synthetic small molecules API are active pharmaceutical ingredients with low molecular weight. The synthetic small molecule API is an organic component used in biological procedures and drug development. Furthermore, any finished pharmaceutical product can utilize API alone or in combination. It is an essential key ingredient in the pharmaceutical sector. The molecule is proven highly effective in the diagnosis, prevention & treatment of the disease. The molecular weight of synthetic small molecule API is 900 Daltons.

MARKET DYNAMICS:

The market for small molecule APIs is influenced by both the increased production of synthetic small molecule APIs as a result of technological advancement in the pharmaceutical industry and the rising need for generic drugs. The demand for synthetic small molecule API has been driven by the need for effective treatments for chronic diseases in several therapeutic fields. The growing ageing population & increase in disease & treatment awareness, the surge in R&D activities, improved healthcare infrastructure, and rising healthcare expenditure are several factors that are contributing to the market growth of synthetic small molecule API. Growth is further accelerated by the demand for raw materials like API for the low-cost manufacturing of drugs & pharmaceuticals. Increasing outsourcing trends and a surge in small-scale production of drugs will further augment the market growth of synthetic small molecule APIs.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of synthetic small molecule api. The growth and trends of synthetic small molecule api industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the synthetic small molecule api market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Manufacturer

  • In-House
  • Outsourced

By Application

  • Cardiology
  • Oncology
  • CNS And Neurology
  • Orthopedic
  • Endocrinology
  • Pulmonology
  • Gastroenterology
  • Nephrology
  • Ophthalmology
  • Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Synthetic Small Molecule API market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the synthetic small molecule api market include Bristol-Myers Squibb Company, Cipla Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., AbbVie Inc., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Viatris Inc., Dr. Reddy's Laboratories Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . SYNTHETIC SMALL MOLECULE API - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Manufacturer
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL SYNTHETIC SMALL MOLECULE API MARKET ANALYSIS BY MANUFACTURER

  • 6.1 Overview by Manufacturer
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Manufacturer
  • 6.4 In-house Historic and Forecast Sales by Regions
  • 6.5 Outsourced Historic and Forecast Sales by Regions

7 . GLOBAL SYNTHETIC SMALL MOLECULE API MARKET ANALYSIS BY APPLICATION

  • 7.1 Overview by Application
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Application
  • 7.4 Cardiology Historic and Forecast Sales by Regions
  • 7.5 Oncology Historic and Forecast Sales by Regions
  • 7.6 CNS And Neurology Historic and Forecast Sales by Regions
  • 7.7 Orthopedic Historic and Forecast Sales by Regions
  • 7.8 Endocrinology Historic and Forecast Sales by Regions
  • 7.9 Pulmonology Historic and Forecast Sales by Regions
  • 7.10. Gastroenterology Historic and Forecast Sales by Regions
  • 7.11 Nephrology Historic and Forecast Sales by Regions
  • 7.12 Ophthalmology Historic and Forecast Sales by Regions
  • 7.13 Others Historic and Forecast Sales by Regions

8 . GLOBAL SYNTHETIC SMALL MOLECULE API MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE SYNTHETIC SMALL MOLECULE API COMPANIES

  • 9.1. Synthetic Small Molecule Api Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF SYNTHETIC SMALL MOLECULE API INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Bristol-Myers Squibb Company
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Cipla Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Boehringer Ingelheim International GmbH
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Merck & Co. Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. AbbVie Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Aurobindo Pharma
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Sun Pharmaceutical Industries Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Teva Pharmaceutical Industries Ltd.
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Albemarle Corporation
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Viatris Inc.
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. Dr. Reddy's Laboratories Ltd.
    • 10.13.1. Company Overview
    • 10.13.2. Company Revenue
    • 10.13.3. Products
    • 10.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies